Immuron Limited ( IMRN) - Stock Earnings
IMRN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 28, 2026, midnight | — / — | — | — / — | — |
IMRN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -606736 USD | 409740 USD |
| 2023Q2 | -1.2 million USD | 810086 USD |
| 2023Q4 | -1.4 million USD | 1.6 million USD |
IMRN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -6.3 million USD | 109306 USD |
| 2022 | -1.8 million USD | 527984 USD |
| 2023 | -2.5 million USD | 1.2 million USD |
IMRN
Price: $1.10
52 week price:
Earnings Per Share: -0.64 USD
P/E Ratio: -1.18
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Australia
Volume: 1327
Ebitda: -6.8 millionMarket Capitalization: 7.1 million